Xin Zhou, PhD

Dr. Xin Zhou received her Ph.D. in Bioengineering from Stanford University with Dr. Michael Lin, where she developed approaches for optogenetic control of kinases and enzymes to spatiotemporally link protein function to signaling outcomes. She then completed a postdoctoral fellowship with Dr. James Wells at UCSF, where she studied biotherapeutics engineering, cancer biology, and immune engineering. Dr. Zhou joined the faculty at Harvard Medical School in 2022. Her lab develops protein engineering technologies to elucidate cancer and immune signaling mechanism and to engineer self-regulated antibodies, enzymes, and cells for therapeutic reprogramming of disease. She is a recipient of the V Foundation Women Scientists Innovation Award for Cancer Research, NIH Director's New Innovator Award (DP2), Damon Runyon–Dale F. Frey Award for Breakthrough Scientists, Helen Gurley Brown Foundation Trailblazer Award, MIT Technology Review Innovators Under 35 (China region), PEGS Protein & Antibody Engineering Summit Young Scientist Keynote Award, and the NIH K99/R00 Pathway to Independence Award.